BIOMARIN PHARMACEUTICAL INC - COM (BMRN)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
177M
Holdings value Q3 2024
$12.4B
Value change Q3 2024
-$673M
Grand Portfolio weight change Q3 2024
-0.001%
Number of holders
534
Number of buys Q3 2024
268
Number of sells Q3 2024
-273
Average buys Q3 2024 %
+0.003%
Average sells Q3 2024 %
-0.006%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 177M $12.4B -$673M $70.29 539
2024 Q2 184M $15.2B +$195M $82.33 550
2024 Q1 183M $16B -$265M $87.34 540
2023 Q4 184M $17.8B +$748M $96.42 531
2023 Q3 177M $15.6B +$7.24M $88.48 505
2023 Q2 177M $15.4B -$56.1M $86.68 541
2023 Q1 178M $17.3B -$367M $97.24 539
2022 Q4 182M $18.8B +$54.4M $103.49 565
2022 Q3 181M $15.4B +$270M $84.77 530
2022 Q2 178M $14.8B +$143M $82.87 518
2022 Q1 177M $13.6B +$46.3M $77.10 536
2021 Q4 176M $15.6B +$126M $88.35 536
2021 Q3 175M $13.5B +$34.2M $77.29 492
2021 Q2 175M $14.6B -$130M $83.44 503
2021 Q1 177M $13.4B -$329M $75.51 509
2020 Q4 182M $15.9B +$288M $87.69 521
2020 Q3 179M $13.6B -$325M $76.08 489
2020 Q2 180M $22.3B +$743M $123.34 519
2020 Q1 176M $14.9B +$296M $84.50 487
2019 Q4 173M $14.6B +$51.2M $84.55 454
2019 Q3 173M $11.7B -$330M $67.40 426
2019 Q2 178M $15.2B +$225M $85.65 470
2019 Q1 178M $15.8B -$79.1M $88.83 476
2018 Q4 179M $15.2B -$187M $85.15 463
2018 Q3 181M $17.5B -$163M $96.97 452
2018 Q2 183M $17.2B +$243M $94.20 444
2018 Q1 180M $14.6B +$188M $81.07 423
2017 Q4 178M $15.8B +$224M $89.17 433
2017 Q3 175M $16.3B +$376M $93.07 405
2017 Q2 169M $15.4B +$218M $90.82 419
2017 Q1 169M $14.8B +$900M $87.78 409
2016 Q4 169M $14B +$54.3M $82.84 409
2016 Q3 168M $15.6B +$821M $92.52 420
2016 Q2 160M $12.4B -$242M $77.80 388
2016 Q1 163M $13.4B +$69.8M $82.48 378
2015 Q4 166M $16.9B +$172M $104.76 383
2015 Q3 159M $16.8B +$118M $105.32 387
2015 Q2 157M $21.4B +$130M $136.78 389
2015 Q1 157M $19.5B +$1.29B $124.62 375
2014 Q4 148M $13.3B +$131M $90.40 338
2014 Q3 148M $10.7B +$238M $72.16 313
2014 Q2 145M $8.99B -$275M $62.21 320
2014 Q1 147M $10.1B +$473M $68.21 309